Alk-Abello AS (AKBLF)
24.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Alk-Abello Gross Profit Margin (Quarterly): 63.10% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 63.10% |
| March 31, 2024 | 65.80% |
| December 31, 2023 | 62.75% |
| September 30, 2023 | 61.71% |
| June 30, 2023 | 62.29% |
| March 31, 2023 | 64.75% |
| December 31, 2022 | 61.73% |
| September 30, 2022 | 60.26% |
| June 30, 2022 | 61.34% |
| March 31, 2022 | 63.98% |
| December 31, 2021 | 63.79% |
| September 30, 2021 | 60.24% |
| June 30, 2021 | 58.29% |
| March 31, 2021 | 61.70% |
| December 31, 2020 | 58.43% |
| September 30, 2020 | 55.44% |
| June 30, 2020 | 56.48% |
| March 31, 2020 | 61.19% |
| December 31, 2019 | 58.32% |
| September 30, 2019 | 60.35% |
| June 30, 2019 | 50.83% |
| March 31, 2019 | 61.36% |
| December 31, 2018 | 55.15% |
| September 30, 2018 | 56.43% |
| June 30, 2018 | 53.99% |
| Date | Value |
|---|---|
| March 31, 2018 | 58.51% |
| December 31, 2017 | 49.28% |
| September 30, 2017 | 56.43% |
| June 30, 2017 | 56.87% |
| March 31, 2017 | 61.98% |
| December 31, 2016 | 63.26% |
| September 30, 2016 | 65.40% |
| June 30, 2016 | 65.46% |
| March 31, 2016 | 70.99% |
| December 31, 2015 | 70.45% |
| September 30, 2015 | 69.12% |
| June 30, 2015 | 61.59% |
| March 31, 2015 | 67.69% |
| December 31, 2014 | 69.44% |
| September 30, 2014 | 64.75% |
| June 30, 2014 | 69.76% |
| March 31, 2014 | 73.83% |
| December 31, 2013 | 68.13% |
| September 30, 2013 | 67.98% |
| June 30, 2013 | 65.98% |
| March 31, 2013 | 73.11% |
| December 31, 2012 | 72.52% |
| September 30, 2012 | 74.67% |
| June 30, 2012 | 68.35% |
| March 31, 2012 | 73.31% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.44%
Minimum
Sep 2020
65.80%
Maximum
Mar 2024
61.10%
Average
61.52%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Genmab AS | 96.48% |
| Ascendis Pharma AS | 68.15% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.30% |
| Return on Assets | 10.29% |
| Return on Invested Capital | 14.21% |
| Profit Margin (Quarterly) | 14.63% |
| Operating Margin (Quarterly) | 19.21% |
| Return on Net Operating Assets | 11.96% |